Journal
Genes
Publication Date
1-6-2023
Volume
14
Issue
1
First Page
153
Document Type
Open Access Publication
DOI
10.3390/genes14010153
Rights and Permissions
Schneider, H.; Hadj-Rabia, S.; Faschingbauer, F.; Bodemer, C.; Grange, D.K.; Norton, M.E.; Cavalli, R.; Tadini, G.; Stepan, H.; Clarke, A.; Guillén-Navarro, E.; Maier-Wohlfart, S.; Bouroubi, A.; Porte, F. Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia. Genes 2023, 14, 153. https://doi.org/10.3390/genes14010153 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Schneider, Holm; Hadj-Rabia, Smail; Faschingbauer, Florian; Bodemer, Christine; Grange, Dorothy K; Norton, Mary E; Cavalli, Riccardo; Tadini, Gianluca; Stepan, Holger; Clarke, Angus; Guillén-Navarro, Encarna; Maier-Wohlfart, Sigrun; Bouroubi, Athmane; and Porte, Florence, "Protocol for the phase 2 EDELIFE trial investigating the efficacy and safety of intra-amniotic ER004 administration to male subjects with X-linked hypohidrotic ectodermal dysplasia." Genes. 14, 1. 153 (2023).
https://digitalcommons.wustl.edu/oa_4/1154
